These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2072 related articles for article (PubMed ID: 23948301)
1. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301 [TBL] [Abstract][Full Text] [Related]
2. Sentinel Node Biopsy Versus Low Axillary Sampling in Predicting Nodal Status of Postchemotherapy Axilla in Women With Breast Cancer. Parmar V; Nair NS; Vanmali V; Hawaldar RW; Siddique S; Shet T; Desai S; Rangarajan V; Patil A; Gupta S; Badwe RA JCO Glob Oncol; 2020 Oct; 6():1546-1553. PubMed ID: 33074737 [TBL] [Abstract][Full Text] [Related]
3. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. Kern KA J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection. van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244 [TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
6. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Crossin JA; Johnson AC; Stewart PB; Turner WW Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279 [TBL] [Abstract][Full Text] [Related]
7. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E Breast J; 2006; 12(3):199-201. PubMed ID: 16684315 [TBL] [Abstract][Full Text] [Related]
8. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633 [TBL] [Abstract][Full Text] [Related]
9. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412 [TBL] [Abstract][Full Text] [Related]
10. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757 [TBL] [Abstract][Full Text] [Related]
11. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer. Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970 [TBL] [Abstract][Full Text] [Related]
12. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810 [TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK; JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169 [TBL] [Abstract][Full Text] [Related]
14. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043 [TBL] [Abstract][Full Text] [Related]
15. [Validation protocol of sentinel node biopsy for breast cancer using radioactive tracer at the Institute of Oncology Bucharest "Prof. Dr. Alexandru Trestioreanu"]. Blidaru A; Bordea C; Voinea S; Condrea I; Albert P; Houcheimi B Chirurgia (Bucur); 2006; 101(4):391-9. PubMed ID: 17059150 [TBL] [Abstract][Full Text] [Related]
16. Axillary reverse mapping in breast cancer: a Canadian experience. Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441 [TBL] [Abstract][Full Text] [Related]
17. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412 [TBL] [Abstract][Full Text] [Related]
18. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Veronesi U; De Cicco C; Galimberti VE; Fernandez JR; Rotmensz N; Viale G; Spano G; Luini A; Intra M; Veronesi P; Berrettini A; Paganelli G Ann Oncol; 2007 Mar; 18(3):473-8. PubMed ID: 17164229 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806 [TBL] [Abstract][Full Text] [Related]
20. Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer. Narui K; Ishikawa T; Kito A; Shimizu D; Chishima T; Momiyama N; Ichikawa Y; Sasaki T; Nozawa A; Inayama Y; Shimada H; Endo I Eur J Surg Oncol; 2010 Aug; 36(8):731-6. PubMed ID: 20609549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]